Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

Market Cap	8.55B -26.7%
Revenue (ttm)	10.50B -15.2%
Net Income	120.57M +352.4%
EPS	0.22 +340.0%
Shares Out	551.42M
PE Ratio	70.50
Forward PE	31.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,314,700
Average Volume	6,827,103
Open	15.51
Previous Close	15.51
Day's Range	15.40 - 15.62
52-Week Range	15.09 - 25.51
Beta	0.45
RSI	34.60
Earnings Date	Apr 30, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 10,864
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.